Safety and Efficacy Analysis of an Antibody Associated With a Chemotherapy for Patients With a Triple Negative Metastatic Breast Cancer
Status: RECRUITING
Study type: INTERVENTIONAL
Conditions: Triple Negative Breast Cancer|Metastatic Breast Cancer
Interventions: DRUG: Sacituzumab govitecan
Sponsor: UNICANCER
Collaborators: Gilead Sciences